Pregled bibliografske jedinice broj: 125697
Synthesis and biological activity of N-(tert-butyloxycarbonyl)-(adamant-2-yl)-D, L-glycyl-peptidoglycan monomer
Synthesis and biological activity of N-(tert-butyloxycarbonyl)-(adamant-2-yl)-D, L-glycyl-peptidoglycan monomer // Peptides 2002 : Proceedings of the Twenty-Seventh European Peptides Symposium / Benedetti, Ettore ; Pedoni, Carlo (ur.).
Napulj: Edizioni Ziino, 2002. str. 616-617 (poster, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni)
CROSBI ID: 125697 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synthesis and biological activity of N-(tert-butyloxycarbonyl)-(adamant-2-yl)-D, L-glycyl-peptidoglycan monomer
Autori
Šporec, Vesna ; Ljevaković, Đurđica ; Halassy Špoljar, Beata ; Frkanec, Ruža ; Krstanović, Marina ; Vranešić, Branka ; Tomašić, Jelka ; Benedetti, F.
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), znanstveni
Izvornik
Peptides 2002 : Proceedings of the Twenty-Seventh European Peptides Symposium
/ Benedetti, Ettore ; Pedoni, Carlo - Napulj : Edizioni Ziino, 2002, 616-617
Skup
Twenty-Seventh European Peptides Symposium
Mjesto i datum
Sorrento, Italija, 31.08.2002. - 06.09.2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
PGM; (N-tert-butyloxycarbonyl)-(adamant-2-yl)-D; L-glycyl-residue
Sažetak
Peptidoglycan monomer (PGM, GlcpNAc-MurpNAc-L-Ala-D-isoGln-L-meso-A2pm(eNH2)-D-Ala-D-Ala, PLIVA), disaccharide pentapeptide, is the basic repeating unit of Brevibacterium divaricatum cell wall peptidoglycan. It exhibits, inter alia, strong immunomodulating activity [1]. Semisynthetic derivatives of peptidoglycan monomer, N-tert-butyloxycarbonyl-L-tyrosyl-PGM and (adamant-1-yl)-acetyl-PGM are good substrates [2] for N-acetylmuramyl-L-alanine amidase present in mammalian blood. Neither of them affected [2] the immunostimulating properties of the parent compound. The aim of this work was to prepare the new derivative of PGM containing (N-tert-butyloxycarbonyl)-(adamant-2-yl)-D, L-glycyl-residue and to investigate the structure-activity relationship. It might be expected that even small structural changes can alter the biological activity of the parent compound. Derivatives of PGM containing the adamantyl residue might combine immunostimulating activity of PGM with antiviral activity of the moiety comprising adamantyl residue. The novel adamantylacyl derivative of PGM was prepared by acylation of e-amino group of diaminopimelic acid with symmetrical anhydride of N-(tert-butyloxycarbonyl)-(adamant-2-yl)-D, L-glycyne. The anhydride was prepared utilizing (a) DCC and (b) EDC. The reaction of the PGM with anhydride (a) gave a mixture of two products N-(tert-butyloxycarbonyl)-D, L-(adamantan-2-yl)-glycyl-peptidoglycan monomer (product A) and [N-(tert-butyloxycarbonyl)-D, L-(adamantan-2-yl)-glycyl]2-peptidoglycan monomer (product B) that have different chromatographical mobilities. The reaction with anhydride (b) resulted in product A only. Products were isolated by gel filtration on Sephadex LH 20 and their structures were confirmed. Activity in relation to the structure of the product A was examined in the two different models: in vitro (the susceptibility of A to the N-acetylmuramyl-L-alanine amidase) and in vivo (immunomodulating activity was tested in an experimental model in mice, using ovalbumin as antigen [1]). Product A was a good substrate for N-acetylmuramyl-L-alanine amidase which cleaves it, yielding the disaccharide and the respective peptide. Immunostimulating activity of product A was compared with the activity of PGM and (adamant-1-yl)-acetyl-PGM. Product A didn't exhibit immunostimulating effect in applied experimental model.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
0021002
Ustanove:
Imunološki zavod d.d.
Profili:
Ruža Frkanec
(autor)
Đurđica Ljevaković
(autor)
Vesna Šporec Dragović
(autor)
Branka Vranešić
(autor)
Jelka Tomašić
(autor)
Beata Halassy
(autor)
Marina Krstanović
(autor)